Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer
Abstract Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors has been described. Recent studies have identified mechanisms for immune evasion based on sialoglycan interactions with immunoregulatory Sigl...
Saved in:
Published in | Glycobiology (Oxford) Vol. 28; no. 9; pp. 640 - 647 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors has been described. Recent studies have identified mechanisms for immune evasion based on sialoglycan interactions with immunoregulatory Siglec receptors that are exploited by tumor cells and microorganisms alike. Siglecs are mostly inhibitory receptors similar to known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies for cancer immunotherapy. Here, we summarize the known changes of sialic acids in cancer and the role Siglec receptors play in cancer immunity. We also focus on potential ways to target these Siglec receptors or sialoglycans in order to improve anti-cancer immunity. |
---|---|
AbstractList | Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors has been described. Recent studies have identified mechanisms for immune evasion based on sialoglycan interactions with immunoregulatory Siglec receptors that are exploited by tumor cells and microorganisms alike. Siglecs are mostly inhibitory receptors similar to known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies for cancer immunotherapy. Here, we summarize the known changes of sialic acids in cancer and the role Siglec receptors play in cancer immunity. We also focus on potential ways to target these Siglec receptors or sialoglycans in order to improve anti-cancer immunity. Abstract Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors has been described. Recent studies have identified mechanisms for immune evasion based on sialoglycan interactions with immunoregulatory Siglec receptors that are exploited by tumor cells and microorganisms alike. Siglecs are mostly inhibitory receptors similar to known immune checkpoints including PD-1 or CTLA-4 that are successfully targeted with blocking antibodies for cancer immunotherapy. Here, we summarize the known changes of sialic acids in cancer and the role Siglec receptors play in cancer immunity. We also focus on potential ways to target these Siglec receptors or sialoglycans in order to improve anti-cancer immunity. |
Author | Stanczak, Michal A von Gunten, Stephan Adams, Olivia Joan Läubli, Heinz |
Author_xml | – sequence: 1 givenname: Olivia Joan surname: Adams fullname: Adams, Olivia Joan organization: Institute of Pharmacology, University of Bern, Inselspital INO-F, Bern, Switzerland – sequence: 2 givenname: Michal A surname: Stanczak fullname: Stanczak, Michal A organization: Laboratory of Cancer Immunology, Department of Biomedicine – sequence: 3 givenname: Stephan surname: von Gunten fullname: von Gunten, Stephan email: stephan.vongunten@pki.unibe.ch organization: Institute of Pharmacology, University of Bern, Inselspital INO-F, Bern, Switzerland – sequence: 4 givenname: Heinz surname: Läubli fullname: Läubli, Heinz email: heinz.laeubli@unibas.ch organization: Laboratory of Cancer Immunology, Department of Biomedicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29309569$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkL1OwzAUhS0Eoj8wsiKPLKG2k7j2iCr-pEoMLXPkODeRUWIHOwG68Q68IU9CUAqM6A5nOJ_Olb4ZOrTOAkJnlFxSIuNFVe-0yxf69Y0ScYCmNOEkYgmLD9GUyFRGnKdigmYhPBFCORXpMZowGQ8dl1O02SpfQWdshYNRtdFYaVN8vn9sTFWDxsZ24JXujLMBdw57eAEfAJum6S3g0LethxCGekCxVlaDP0FHpaoDnO5zjh5vrreru2j9cHu_ulpHOolpFzEidZlSWlJJCpIOR2RJl0wIXqhlUqgiKRmlkCsNpaRcSAJK8HyZF4IwRuI5uhh3W--eewhd1pigoa6VBdeHjEoh01RIFg9oNKLauxA8lFnrTaP8LqMk-_aYjR6z0ePAn--n-7yB4pf-Eff32_XtP1tfcH2BwA |
CitedBy_id | crossref_primary_10_1007_s11696_021_02026_7 crossref_primary_10_3390_ijms22115774 crossref_primary_10_1159_000507003 crossref_primary_10_3389_frhem_2024_1360149 crossref_primary_10_1021_acscentsci_0c01669 crossref_primary_10_3390_jcm9092967 crossref_primary_10_1007_s00018_019_03288_x crossref_primary_10_3389_fimmu_2020_00167 crossref_primary_10_1007_s00262_019_02332_w crossref_primary_10_3390_ijms22147494 crossref_primary_10_3389_fonc_2018_00068 crossref_primary_10_1360_SSV_2022_0067 crossref_primary_10_1038_s41374_022_00796_6 crossref_primary_10_3389_fimmu_2018_02138 crossref_primary_10_3389_fonc_2021_710689 crossref_primary_10_1007_s12649_020_01308_7 crossref_primary_10_3389_fimmu_2019_00959 crossref_primary_10_3389_fonc_2020_586820 crossref_primary_10_3390_cells10051100 crossref_primary_10_1021_acscentsci_1c00064 crossref_primary_10_1021_jacs_9b05769 crossref_primary_10_1158_0008_5472_CAN_17_3376 crossref_primary_10_1021_acs_bioconjchem_2c00227 crossref_primary_10_3389_fonc_2021_608113 crossref_primary_10_1038_s41423_024_01142_0 crossref_primary_10_1021_acsami_0c15212 crossref_primary_10_3389_fimmu_2023_1121285 crossref_primary_10_3390_cancers10060207 crossref_primary_10_3390_molecules27134285 crossref_primary_10_3389_fimmu_2019_02120 crossref_primary_10_1021_acs_orglett_1c00612 crossref_primary_10_3389_fimmu_2018_02807 crossref_primary_10_1007_s00428_018_2435_9 crossref_primary_10_3389_fimmu_2021_799861 crossref_primary_10_1002_cpz1_646 crossref_primary_10_1007_s11010_018_3478_6 crossref_primary_10_1021_jacs_2c00922 crossref_primary_10_3390_ijms22042000 crossref_primary_10_1042_BST20170483 crossref_primary_10_1096_fba_2020_00092 crossref_primary_10_3389_fimmu_2022_847581 crossref_primary_10_3389_fimmu_2021_613530 crossref_primary_10_1152_ajpcell_00063_2022 crossref_primary_10_1021_acscentsci_0c00601 crossref_primary_10_1080_10408398_2022_2136620 |
Cites_doi | 10.1016/j.immuni.2011.10.014 10.1074/jbc.M114.574624 10.1182/blood-2014-08-596403 10.1073/pnas.1608069113 10.1074/jbc.M113.523753 10.1038/bjc.1968.99 10.4049/jimmunol.181.9.6625 10.1016/j.cell.2015.03.030 10.1007/s00018-014-1799-5 10.1126/scitranslmed.3010524 10.1093/glycob/cwr087 10.1182/blood-2004-10-4112 10.1021/nn5061964 10.1007/s11030-006-9029-1 10.1016/j.bcp.2011.05.018 10.1007/s00109-015-1341-8 10.1182/blood-2009-12-257386 10.3389/fimmu.2017.00314 10.1016/j.immuni.2012.03.004 10.1111/j.1349-7006.2009.01455.x 10.1038/nri3737 10.1016/j.ccell.2015.03.001 10.1016/S1521-6616(03)00036-6 10.1074/jbc.273.42.27199 10.1158/0008-5472.CAN-14-0728 10.1038/ni.3535 10.1073/pnas.0404833101 10.1093/glycob/cwu044 10.1182/blood-2006-05-021568 10.4049/jimmunol.1700898 10.1126/science.1168988 10.1007/s10719-006-6734-z 10.1007/s10719-008-9183-z 10.1038/nchembio.1388 10.1016/j.mam.2016.07.002 10.1084/jem.20030635 10.1002/eji.200323693 10.1097/00007890-196709000-00005 10.1073/pnas.1409580111 10.1016/S0300-9084(01)01303-7 10.1038/nrc3982 10.7554/eLife.06184 10.1093/glycob/cwv051 10.1182/blood-2012-08-449983 10.1084/jem.20131853 10.1111/j.1749-6632.2011.06304.x 10.4049/jimmunol.168.5.2523 10.1038/s41467-017-00836-6 10.1073/pnas.1219888110 10.1016/j.bbagen.2014.06.006 10.1016/j.cell.2013.01.011 10.1016/j.carres.2014.02.004 10.1074/jbc.M111.243410 10.1007/s00253-012-4040-1 10.18632/oncotarget.9419 10.3389/fimmu.2014.00325 10.1074/jbc.M604221200 10.1096/fj.13-241497 10.15252/embj.201695581 10.1007/s10555-012-9359-7 10.1200/JCO.2012.43.0132 10.1007/BF00749902 10.1074/jbc.M114.593129 10.1046/j.1432-1033.2003.03927.x 10.1146/annurev.iy.02.040184.000535 10.18632/oncotarget.6822 10.3109/10428194.2011.604755 10.1073/pnas.2131556100 10.1097/ACI.0000000000000234 10.1002/ijc.2910150307 10.1073/pnas.1417508112 10.1023/A:1011062223612 10.1084/jem.20090691 10.1093/glycob/cwx026 10.1093/glycob/cwu067 10.1038/ni.3552 10.1038/ni.2610 10.1007/978-3-319-11280-0_1 10.1074/jbc.M115.691337 10.3389/fonc.2012.00170 10.1093/glycob/cwp063 10.1073/pnas.1507706113 10.1038/nrc1649 10.1172/JCI65899 10.1074/jbc.M116.738351 10.1196/annals.1443.011 10.1038/nri2056 10.1023/A:1007026314792 10.1093/glycob/cwv097 10.1182/blood-2008-11-187302 10.1111/j.1365-2567.2010.03368.x 10.1111/imr.12526 10.1146/annurev-immunol-020711-075018 10.1074/jbc.M001123200 10.1073/pnas.0803943105 |
ContentType | Journal Article |
Copyright | The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 |
Copyright_xml | – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1093/glycob/cwx108 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
DocumentTitleAlternate | Special Issue: Cancer Immunotherapy |
EISSN | 1460-2423 |
EndPage | 647 |
ExternalDocumentID | 10_1093_glycob_cwx108 29309569 10.1093/glycob/cwx108 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: Schoenmakers Foundation – fundername: Swiss Cancer League/Swiss Cancer Research grantid: KFS-3941-08-2016; KFS-3248-08-2013 – fundername: Promedica Foundation – fundername: Swiss National Science Foundation (SNSF) grantid: 310030_162552/1 – fundername: Goldschmidt-Jacobson Foundation |
GroupedDBID | --- -E4 .2P .GJ .I3 .ZR 0R~ 1TH 29I 2WC 4.4 482 48X 53G 5GY 5VS 5WA 5WD 6.Y 70D A8Z AABZA AACZT AAHBH AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAVLN AAWDT ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFS ACIWK ACMRT ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHXPO AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM C1A C45 CAG CDBKE COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD ELUNK EMOBN ESTFP F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 KAQDR KBUDW KC5 KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OBS OCZFY ODMLO OEB OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RHF RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H Y6R YAYTL YKOAZ YXANX ZKX ~91 ~KM CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c431t-209cf511f190d0505009f172886da74dad4f211ebacef916890ea86b7bd802203 |
ISSN | 0959-6658 |
IngestDate | Fri Aug 16 20:40:54 EDT 2024 Thu Sep 12 19:28:48 EDT 2024 Wed Oct 16 00:47:27 EDT 2024 Wed Aug 28 03:21:03 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | blocking antibodies acetyl-neuraminic acid immune evasion glycolyl-neuraminic acid hypersialylation cancer immunotherapy |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices) |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c431t-209cf511f190d0505009f172886da74dad4f211ebacef916890ea86b7bd802203 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://academic.oup.com/glycob/article-pdf/28/9/640/25510592/cwx108.pdf |
PMID | 29309569 |
PQID | 1989558923 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1989558923 crossref_primary_10_1093_glycob_cwx108 pubmed_primary_29309569 oup_primary_10_1093_glycob_cwx108 |
PublicationCentury | 2000 |
PublicationDate | 2018-09-01 |
PublicationDateYYYYMMDD | 2018-09-01 |
PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Glycobiology (Oxford) |
PublicationTitleAlternate | Glycobiology |
PublicationYear | 2018 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Chen ( key 20180328170405_cwx108C22) 2012; 53 Läubli ( key 20180328170405_cwx108C49) 2014; 111 Padler-Karavani ( key 20180328170405_cwx108C61) 2014; 28 Diaz ( key 20180328170405_cwx108C29) 2003; 107 Li ( key 20180328170405_cwx108C50) 2012; 94 Perdicchio ( key 20180328170405_cwx108C63) 2016; 7 Tachibana ( key 20180328170405_cwx108C86) 1994; 16 Pearce ( key 20180328170405_cwx108C62) 2016; 26 Läubli ( key 20180328170405_cwx108C48) 2014; 289 Schwarz ( key 20180328170405_cwx108C77) 2015; 842 Alfonso ( key 20180328170405_cwx108C1) 2002; 168 Naito-Matsui ( key 20180328170405_cwx108C59) 2014; 289 Amon ( key 20180328170405_cwx108C5) 2014; 389 Rabinovich ( key 20180328170405_cwx108C67) 2012; 36 Varki ( key 20180328170405_cwx108C93) 2011; 21 Sanford ( key 20180328170405_cwx108C72) 1967; 5 Boligan ( key 20180328170405_cwx108C12) 2015; 72 Fraschilla ( key 20180328170405_cwx108C33) 2017; 276 von Gunten ( key 20180328170405_cwx108C97) 2006; 108 Berger ( key 20180328170405_cwx108C11) 1969; 75 Schwarz ( key 20180328170405_cwx108C78) 2017; 36 Angata ( key 20180328170405_cwx108C6) 2006; 10 Sedlacek ( key 20180328170405_cwx108C81) 1975; 15 Carlin ( key 20180328170405_cwx108C17) 2009; 206 Clark ( key 20180328170405_cwx108C24) 2012; 1253 Schultz ( key 20180328170405_cwx108C76) 2012; 31 Beatson ( key 20180328170405_cwx108C9) 2016; 17 Silva ( key 20180328170405_cwx108C85) 2016; 7 Kawasaki ( key 20180328170405_cwx108C46) 2013; 110 Alisson-Silva ( key 20180328170405_cwx108C3) 2016; 51 Ereno-Orbea ( key 20180328170405_cwx108C31) 2017; 8 Secundino ( key 20180328170405_cwx108C80) 2015; 94 Jabbour ( key 20180328170405_cwx108C41) 2015; 125 Ding ( key 20180328170405_cwx108C30) 2016; 17 Büll ( key 20180328170405_cwx108C14) 2015; 9 Angata ( key 20180328170405_cwx108C7) 2004; 101 Chen ( key 20180328170405_cwx108C20) 2010; 115 Macauley ( key 20180328170405_cwx108C52) 2014; 14 Hedlund ( key 20180328170405_cwx108C37) 2008; 105 Crocker ( key 20180328170405_cwx108C26) 2007; 7 Schleimer ( key 20180328170405_cwx108C74) 2016; 16 Go ( key 20180328170405_cwx108C35) 2006; 23 Bandala-Sanchez ( key 20180328170405_cwx108C8) 2013; 14 Bednar ( key 20180328170405_cwx108C10) 2017; 199 Inoue ( key 20180328170405_cwx108C40) 1998; 273 Ali ( key 20180328170405_cwx108C2) 2014; 211 Fuster ( key 20180328170405_cwx108C34) 2005; 5 Fedarko ( key 20180328170405_cwx108C32) 2000; 275 Hernandez ( key 20180328170405_cwx108C38) 2008; 181 Yu ( key 20180328170405_cwx108C101) 2017; 27 Mikulak ( key 20180328170405_cwx108C57) 2017; 8 Pinho ( key 20180328170405_cwx108C66) 2015; 15 Dall’Olio ( key 20180328170405_cwx108C28) 2014; 1840 Borys ( key 20180328170405_cwx108C13) 1993; 11 Hudak ( key 20180328170405_cwx108C39) 2014; 10 Hakomori ( key 20180328170405_cwx108C36) 1984; 2 Chen ( key 20180328170405_cwx108C21) 2013; 152 Pillai ( key 20180328170405_cwx108C65) 2012; 30 Sharma ( key 20180328170405_cwx108C82) 2015; 161 Corfield ( key 20180328170405_cwx108C25) 1999; 16 McMillan ( key 20180328170405_cwx108C55) 2013; 121 Büll ( key 20180328170405_cwx108C15) 2014; 74 Malykh ( key 20180328170405_cwx108C54) 2001; 83 Nagamune ( key 20180328170405_cwx108C58) 2004; 199 Topalian ( key 20180328170405_cwx108C89) 2015; 27 Wang ( key 20180328170405_cwx108C99) 2015; 25 Perdicchio ( key 20180328170405_cwx108C64) 2016; 113 Schneider ( key 20180328170405_cwx108C75) 2015; 7 Siddiqui ( key 20180328170405_cwx108C84) 2017; 292 Takagi ( key 20180328170405_cwx108C87) 2011; 35 Varki ( key 20180328170405_cwx108C92) 2009; 19 Jandus ( key 20180328170405_cwx108C43) 2014; 124 Nicoll ( key 20180328170405_cwx108C60) 2003; 33 Currie ( key 20180328170405_cwx108C27) 1968; 22 Urbanitz ( key 20180328170405_cwx108C90) 1987; 30 Carlin ( key 20180328170405_cwx108C18) 2009; 113 Krengel ( key 20180328170405_cwx108C47) 2014; 5 von Gunten ( key 20180328170405_cwx108C96) 2008; 1143 Xiao ( key 20180328170405_cwx108C100) 2016; 113 Linnartz-Gerlach ( key 20180328170405_cwx108C51) 2014; 24 Samraj ( key 20180328170405_cwx108C70) 2014; 4 Jabbour ( key 20180328170405_cwx108C42) 2017 Samraj ( key 20180328170405_cwx108C71) 2015; 112 Varki ( key 20180328170405_cwx108C91) 2009; 26 Schauer ( key 20180328170405_cwx108C73) 2000; 17 Vazquez ( key 20180328170405_cwx108C95) 2012; 2 Cao ( key 20180328170405_cwx108C16) 2011; 132 Altheide ( key 20180328170405_cwx108C4) 2006; 281 Shen ( key 20180328170405_cwx108C83) 2004; 271 Varki ( key 20180328170405_cwx108C94) 2015 Schwarz ( key 20180328170405_cwx108C79) 2015; 4 Tangvoranuntakul ( key 20180328170405_cwx108C88) 2003; 100 Macauley ( key 20180328170405_cwx108C53) 2015; 290 Jandus ( key 20180328170405_cwx108C44) 2011; 82 McMillan ( key 20180328170405_cwx108C56) 2014; 289 Ravandi ( key 20180328170405_cwx108C68) 2012; 30 Redelinghuys ( key 20180328170405_cwx108C69) 2011; 286 Chen ( key 20180328170405_cwx108C23) 2009; 323 von Gunten ( key 20180328170405_cwx108C98) 2005; 106 Kannagi ( key 20180328170405_cwx108C45) 2010; 101 Chang ( key 20180328170405_cwx108C19) 2014; 24 |
References_xml | – volume: 35 start-page: 958 year: 2011 ident: key 20180328170405_cwx108C87 article-title: Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo publication-title: Immunity doi: 10.1016/j.immuni.2011.10.014 contributor: fullname: Takagi – volume: 289 start-page: 20370 year: 2014 ident: key 20180328170405_cwx108C56 article-title: Siglec-E promotes beta2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung publication-title: J Biol Chem doi: 10.1074/jbc.M114.574624 contributor: fullname: McMillan – volume: 4 start-page: 33 year: 2014 ident: key 20180328170405_cwx108C70 article-title: Involvement of a non-human sialic acid in human cancer publication-title: Front Oncol contributor: fullname: Samraj – volume: 125 start-page: 4010 year: 2015 ident: key 20180328170405_cwx108C41 article-title: Monoclonal antibodies in acute lymphoblastic leukemia publication-title: Blood doi: 10.1182/blood-2014-08-596403 contributor: fullname: Jabbour – volume: 113 start-page: 10304 year: 2016 ident: key 20180328170405_cwx108C100 article-title: Precision glycocalyx editing as a strategy for cancer immunotherapy publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1608069113 contributor: fullname: Xiao – volume: 289 start-page: 1564 year: 2014 ident: key 20180328170405_cwx108C59 article-title: Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells publication-title: J Biol Chem doi: 10.1074/jbc.M113.523753 contributor: fullname: Naito-Matsui – volume: 22 start-page: 843 year: 1968 ident: key 20180328170405_cwx108C27 article-title: The role of sialic acid in antigenic expression: Further studies of the Landschutz ascites tumour publication-title: Br J Cancer doi: 10.1038/bjc.1968.99 contributor: fullname: Currie – volume: 181 start-page: 6625 year: 2008 ident: key 20180328170405_cwx108C38 article-title: Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody publication-title: J Immunol doi: 10.4049/jimmunol.181.9.6625 contributor: fullname: Hernandez – volume: 161 start-page: 205 year: 2015 ident: key 20180328170405_cwx108C82 article-title: Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential publication-title: Cell doi: 10.1016/j.cell.2015.03.030 contributor: fullname: Sharma – volume: 72 start-page: 1231 year: 2015 ident: key 20180328170405_cwx108C12 article-title: Cancer intelligence acquired (CIA): Tumor glycosylation and sialylation codes dismantling antitumor defense publication-title: Cell Mol Life Sci doi: 10.1007/s00018-014-1799-5 contributor: fullname: Boligan – volume: 7 start-page: 269ra261 year: 2015 ident: key 20180328170405_cwx108C75 article-title: The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3010524 contributor: fullname: Schneider – volume: 21 start-page: 1121 year: 2011 ident: key 20180328170405_cwx108C93 article-title: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them publication-title: Glycobiology doi: 10.1093/glycob/cwr087 contributor: fullname: Varki – volume: 106 start-page: 1423 year: 2005 ident: key 20180328170405_cwx108C98 article-title: Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment publication-title: Blood doi: 10.1182/blood-2004-10-4112 contributor: fullname: von Gunten – volume: 9 start-page: 733 year: 2015 ident: key 20180328170405_cwx108C14 article-title: Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread publication-title: ACS Nano doi: 10.1021/nn5061964 contributor: fullname: Büll – volume: 10 start-page: 555 year: 2006 ident: key 20180328170405_cwx108C6 article-title: Molecular diversity and evolution of the Siglec family of cell-surface lectins publication-title: Mol Divers doi: 10.1007/s11030-006-9029-1 contributor: fullname: Angata – volume: 82 start-page: 323 year: 2011 ident: key 20180328170405_cwx108C44 article-title: Targeting siglecs – a novel pharmacological strategy for immuno- and glycotherapy publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.05.018 contributor: fullname: Jandus – volume: 94 start-page: 219 issue: 2 year: 2015 ident: key 20180328170405_cwx108C80 article-title: Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation publication-title: J Mol Med (Berl) doi: 10.1007/s00109-015-1341-8 contributor: fullname: Secundino – volume: 115 start-page: 4778 year: 2010 ident: key 20180328170405_cwx108C20 article-title: In vivo targeting of B-cell lymphoma with glycan ligands of CD22 publication-title: Blood doi: 10.1182/blood-2009-12-257386 contributor: fullname: Chen – volume: 8 start-page: 314 year: 2017 ident: key 20180328170405_cwx108C57 article-title: Host immune responses in HIV-1 infection: The emerging pathogenic role of siglecs and their clinical correlates publication-title: Front Immunol doi: 10.3389/fimmu.2017.00314 contributor: fullname: Mikulak – volume: 36 start-page: 322 year: 2012 ident: key 20180328170405_cwx108C67 article-title: Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer publication-title: Immunity doi: 10.1016/j.immuni.2012.03.004 contributor: fullname: Rabinovich – volume: 101 start-page: 586 year: 2010 ident: key 20180328170405_cwx108C45 article-title: Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2009.01455.x contributor: fullname: Kannagi – volume: 14 start-page: 653 year: 2014 ident: key 20180328170405_cwx108C52 article-title: Siglec-mediated regulation of immune cell function in disease publication-title: Nat Rev Immunol doi: 10.1038/nri3737 contributor: fullname: Macauley – volume: 75 start-page: 269 year: 1969 ident: key 20180328170405_cwx108C11 article-title: Application of immunofluorescence to renal pathology. II. Immunohistochemical study of glomerular lesions publication-title: J Urol Nephrol (Paris) contributor: fullname: Berger – volume: 27 start-page: 450 year: 2015 ident: key 20180328170405_cwx108C89 article-title: Immune checkpoint blockade: A common denominator approach to cancer therapy publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.03.001 contributor: fullname: Topalian – volume: 107 start-page: 80 year: 2003 ident: key 20180328170405_cwx108C29 article-title: Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides publication-title: Clin Immunol doi: 10.1016/S1521-6616(03)00036-6 contributor: fullname: Diaz – volume: 273 start-page: 27199 year: 1998 ident: key 20180328170405_cwx108C40 article-title: Identification of free deaminated sialic acid (2-keto-3-deoxy-D-glycero-D-galacto-nononic acid) in human red blood cells and its elevated expression in fetal cord red blood cells and ovarian cancer cells publication-title: J Biol Chem doi: 10.1074/jbc.273.42.27199 contributor: fullname: Inoue – volume: 74 start-page: 3199 year: 2014 ident: key 20180328170405_cwx108C15 article-title: Sialic acids sweeten a tumor’s life publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-0728 contributor: fullname: Büll – volume: 17 start-page: 1167 year: 2016 ident: key 20180328170405_cwx108C30 article-title: The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation publication-title: Nat Immunol doi: 10.1038/ni.3535 contributor: fullname: Ding – volume: 101 start-page: 13251 year: 2004 ident: key 20180328170405_cwx108C7 article-title: Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0404833101 contributor: fullname: Angata – volume: 24 start-page: 794 year: 2014 ident: key 20180328170405_cwx108C51 article-title: Siglec functions of microglia publication-title: Glycobiology doi: 10.1093/glycob/cwu044 contributor: fullname: Linnartz-Gerlach – volume-title: Essentials of Glycobiology year: 2015 ident: key 20180328170405_cwx108C94 contributor: fullname: Varki – volume: 108 start-page: 4255 year: 2006 ident: key 20180328170405_cwx108C97 article-title: Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations publication-title: Blood doi: 10.1182/blood-2006-05-021568 contributor: fullname: von Gunten – volume: 199 start-page: 3116 year: 2017 ident: key 20180328170405_cwx108C10 article-title: Human CD22 inhibits murine B cell receptor activation in a human CD22 transgenic mouse model publication-title: J Immunol doi: 10.4049/jimmunol.1700898 contributor: fullname: Bednar – volume: 323 start-page: 1722 year: 2009 ident: key 20180328170405_cwx108C23 article-title: CD24 and Siglec-10 selectively repress tissue damage-induced immune responses publication-title: Science doi: 10.1126/science.1168988 contributor: fullname: Chen – volume: 23 start-page: 411 year: 2006 ident: key 20180328170405_cwx108C35 article-title: Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs publication-title: Glycoconj J doi: 10.1007/s10719-006-6734-z contributor: fullname: Go – volume: 26 start-page: 231 year: 2009 ident: key 20180328170405_cwx108C91 article-title: Multiple changes in sialic acid biology during human evolution publication-title: Glycoconj J doi: 10.1007/s10719-008-9183-z contributor: fullname: Varki – volume: 10 start-page: 69 year: 2014 ident: key 20180328170405_cwx108C39 article-title: Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion publication-title: Nat Chem Biol doi: 10.1038/nchembio.1388 contributor: fullname: Hudak – volume: 51 start-page: 16 year: 2016 ident: key 20180328170405_cwx108C3 article-title: Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid publication-title: Mol Aspects Med doi: 10.1016/j.mam.2016.07.002 contributor: fullname: Alisson-Silva – volume: 199 start-page: 1445 year: 2004 ident: key 20180328170405_cwx108C58 article-title: Surface sialic acids taken from the host allow trypanosome survival in tsetse fly vectors publication-title: J Exp Med doi: 10.1084/jem.20030635 contributor: fullname: Nagamune – volume: 33 start-page: 1642 year: 2003 ident: key 20180328170405_cwx108C60 article-title: Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms publication-title: Eur J Immunol doi: 10.1002/eji.200323693 contributor: fullname: Nicoll – volume: 5 start-page: 1273 year: 1967 ident: key 20180328170405_cwx108C72 article-title: An alteration in tumor histocompatibility induced by neuraminidase publication-title: Transplantation doi: 10.1097/00007890-196709000-00005 contributor: fullname: Sanford – volume: 111 start-page: 14211 year: 2014 ident: key 20180328170405_cwx108C49 article-title: Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1409580111 contributor: fullname: Läubli – volume: 83 start-page: 623 year: 2001 ident: key 20180328170405_cwx108C54 article-title: N-glycolylneuraminic acid in human tumours publication-title: Biochimie doi: 10.1016/S0300-9084(01)01303-7 contributor: fullname: Malykh – year: 2017 ident: key 20180328170405_cwx108C42 article-title: Salvage chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD for patients with relapsed or refractory philadelphia chromosome-negative acute lymphoblastic leukemia: A Phase 2 Clinical Trial publication-title: JAMA Oncol contributor: fullname: Jabbour – volume: 15 start-page: 540 year: 2015 ident: key 20180328170405_cwx108C66 article-title: Glycosylation in cancer: Mechanisms and clinical implications publication-title: Nat Rev Cancer doi: 10.1038/nrc3982 contributor: fullname: Pinho – volume: 4 start-page: e06184 year: 2015 ident: key 20180328170405_cwx108C79 article-title: Siglec receptors impact mammalian lifespan by modulating oxidative stress publication-title: Elife doi: 10.7554/eLife.06184 contributor: fullname: Schwarz – volume: 25 start-page: 1362 year: 2015 ident: key 20180328170405_cwx108C99 article-title: LC-MS/MS glycomic analyses of free and conjugated forms of the sialic acids, Neu5Ac, Neu5Gc and KDN in human throat cancers publication-title: Glycobiology doi: 10.1093/glycob/cwv051 contributor: fullname: Wang – volume: 121 start-page: 2084 year: 2013 ident: key 20180328170405_cwx108C55 article-title: Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b beta2-integrin-dependent signaling publication-title: Blood doi: 10.1182/blood-2012-08-449983 contributor: fullname: McMillan – volume: 211 start-page: 1231 year: 2014 ident: key 20180328170405_cwx108C2 article-title: Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus publication-title: J Exp Med doi: 10.1084/jem.20131853 contributor: fullname: Ali – volume: 1253 start-page: 58 year: 2012 ident: key 20180328170405_cwx108C24 article-title: T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2011.06304.x contributor: fullname: Clark – volume: 168 start-page: 2523 year: 2002 ident: key 20180328170405_cwx108C1 article-title: An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients publication-title: J Immunol doi: 10.4049/jimmunol.168.5.2523 contributor: fullname: Alfonso – volume: 8 start-page: 764 year: 2017 ident: key 20180328170405_cwx108C31 article-title: Molecular basis of human CD22 function and therapeutic targeting publication-title: Nat Commun doi: 10.1038/s41467-017-00836-6 contributor: fullname: Ereno-Orbea – volume: 110 start-page: 7826 year: 2013 ident: key 20180328170405_cwx108C46 article-title: Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1219888110 contributor: fullname: Kawasaki – volume: 1840 start-page: 2752 year: 2014 ident: key 20180328170405_cwx108C28 article-title: Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagen.2014.06.006 contributor: fullname: Dall’Olio – volume: 152 start-page: 467 year: 2013 ident: key 20180328170405_cwx108C21 article-title: Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation publication-title: Cell doi: 10.1016/j.cell.2013.01.011 contributor: fullname: Chen – volume: 389 start-page: 115 year: 2014 ident: key 20180328170405_cwx108C5 article-title: Glycans in immune recognition and response publication-title: Carbohydr Res doi: 10.1016/j.carres.2014.02.004 contributor: fullname: Amon – volume: 286 start-page: 34522 year: 2011 ident: key 20180328170405_cwx108C69 article-title: Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E publication-title: J Biol Chem doi: 10.1074/jbc.M111.243410 contributor: fullname: Redelinghuys – volume: 94 start-page: 887 year: 2012 ident: key 20180328170405_cwx108C50 article-title: Sialic acid metabolism and sialyltransferases: Natural functions and applications publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-012-4040-1 contributor: fullname: Li – volume: 7 start-page: 41053 year: 2016 ident: key 20180328170405_cwx108C85 article-title: Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses publication-title: Oncotarget doi: 10.18632/oncotarget.9419 contributor: fullname: Silva – volume: 5 start-page: 325 year: 2014 ident: key 20180328170405_cwx108C47 article-title: Molecular recognition of gangliosides and their potential for cancer immunotherapies publication-title: Front Immunol doi: 10.3389/fimmu.2014.00325 contributor: fullname: Krengel – volume: 281 start-page: 25689 year: 2006 ident: key 20180328170405_cwx108C4 article-title: System-wide genomic and biochemical comparisons of sialic acid biology among primates and rodents: Evidence for two modes of rapid evolution publication-title: J Biol Chem doi: 10.1074/jbc.M604221200 contributor: fullname: Altheide – volume: 28 start-page: 1280 year: 2014 ident: key 20180328170405_cwx108C61 article-title: Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates publication-title: FASEB J doi: 10.1096/fj.13-241497 contributor: fullname: Padler-Karavani – volume: 36 start-page: 751 year: 2017 ident: key 20180328170405_cwx108C78 article-title: Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen publication-title: EMBO J doi: 10.15252/embj.201695581 contributor: fullname: Schwarz – volume: 30 start-page: 64 year: 1987 ident: key 20180328170405_cwx108C90 article-title: Neuraminidase-treated allogeneic blasts for maintenance in acute myelogenous leukemia: Results of a prospective randomized trial publication-title: Haematol Blood Transfus contributor: fullname: Urbanitz – volume: 31 start-page: 501 year: 2012 ident: key 20180328170405_cwx108C76 article-title: Regulation of the metastatic cell phenotype by sialylated glycans publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-012-9359-7 contributor: fullname: Schultz – volume: 30 start-page: 3921 year: 2012 ident: key 20180328170405_cwx108C68 article-title: Gemtuzumab ozogamicin: Time to resurrect? publication-title: J Clin Oncol doi: 10.1200/JCO.2012.43.0132 contributor: fullname: Ravandi – volume: 16 start-page: 151 year: 1994 ident: key 20180328170405_cwx108C86 article-title: Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody publication-title: Cytotechnology doi: 10.1007/BF00749902 contributor: fullname: Tachibana – volume: 289 start-page: 33481 year: 2014 ident: key 20180328170405_cwx108C48 article-title: Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs publication-title: J Biol Chem doi: 10.1074/jbc.M114.593129 contributor: fullname: Läubli – volume: 271 start-page: 281 year: 2004 ident: key 20180328170405_cwx108C83 article-title: O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma publication-title: Eur J Biochem doi: 10.1046/j.1432-1033.2003.03927.x contributor: fullname: Shen – volume: 2 start-page: 103 year: 1984 ident: key 20180328170405_cwx108C36 article-title: Tumor-associated carbohydrate antigens publication-title: Annu Rev Immunol doi: 10.1146/annurev.iy.02.040184.000535 contributor: fullname: Hakomori – volume: 7 start-page: 8771 year: 2016 ident: key 20180328170405_cwx108C63 article-title: Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells publication-title: Oncotarget doi: 10.18632/oncotarget.6822 contributor: fullname: Perdicchio – volume: 53 start-page: 208 year: 2012 ident: key 20180328170405_cwx108C22 article-title: Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22 publication-title: Leuk Lymphoma doi: 10.3109/10428194.2011.604755 contributor: fullname: Chen – volume: 100 start-page: 12045 year: 2003 ident: key 20180328170405_cwx108C88 article-title: Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2131556100 contributor: fullname: Tangvoranuntakul – volume: 16 start-page: 24 year: 2016 ident: key 20180328170405_cwx108C74 article-title: Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/ACI.0000000000000234 contributor: fullname: Schleimer – volume: 15 start-page: 409 year: 1975 ident: key 20180328170405_cwx108C81 article-title: Regression of spontaneous mammary tumors in dogs after injection of neuraminidase-treated tumor cells publication-title: Int J Cancer doi: 10.1002/ijc.2910150307 contributor: fullname: Sedlacek – volume: 112 start-page: 542 year: 2015 ident: key 20180328170405_cwx108C71 article-title: A red meat-derived glycan promotes inflammation and cancer progression publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1417508112 contributor: fullname: Samraj – volume: 17 start-page: 485 year: 2000 ident: key 20180328170405_cwx108C73 article-title: Achievements and challenges of sialic acid research publication-title: Glycoconj J doi: 10.1023/A:1011062223612 contributor: fullname: Schauer – volume: 206 start-page: 1691 year: 2009 ident: key 20180328170405_cwx108C17 article-title: Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5 publication-title: J Exp Med doi: 10.1084/jem.20090691 contributor: fullname: Carlin – volume: 27 start-page: 657 year: 2017 ident: key 20180328170405_cwx108C101 article-title: Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties publication-title: Glycobiology doi: 10.1093/glycob/cwx026 contributor: fullname: Yu – volume: 24 start-page: 818 year: 2014 ident: key 20180328170405_cwx108C19 article-title: The interplay between Siglecs and sialylated pathogens publication-title: Glycobiology doi: 10.1093/glycob/cwu067 contributor: fullname: Chang – volume: 11 start-page: 720 year: 1993 ident: key 20180328170405_cwx108C13 article-title: Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells publication-title: Biotechnology (N Y) contributor: fullname: Borys – volume: 17 start-page: 1273 issue: 11 year: 2016 ident: key 20180328170405_cwx108C9 article-title: The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9 publication-title: Nat Immunol doi: 10.1038/ni.3552 contributor: fullname: Beatson – volume: 14 start-page: 741 year: 2013 ident: key 20180328170405_cwx108C8 article-title: T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10 publication-title: Nat Immunol doi: 10.1038/ni.2610 contributor: fullname: Bandala-Sanchez – volume: 842 start-page: 1 year: 2015 ident: key 20180328170405_cwx108C77 article-title: Human-specific evolutionary changes in the biology of siglecs publication-title: Adv Exp Med Biol doi: 10.1007/978-3-319-11280-0_1 contributor: fullname: Schwarz – volume: 290 start-page: 30066 year: 2015 ident: key 20180328170405_cwx108C53 article-title: Unmasking of CD22 co-receptor on germinal center B-cells occurs by alternative mechanisms in mouse and man publication-title: J Biol Chem doi: 10.1074/jbc.M115.691337 contributor: fullname: Macauley – volume: 2 start-page: 170 year: 2012 ident: key 20180328170405_cwx108C95 article-title: Anti-ganglioside anti-idiotypic vaccination: More than molecular mimicry publication-title: Front Oncol doi: 10.3389/fonc.2012.00170 contributor: fullname: Vazquez – volume: 19 start-page: 810 year: 2009 ident: key 20180328170405_cwx108C92 article-title: Natural ligands for CD33-related Siglecs? publication-title: Glycobiology doi: 10.1093/glycob/cwp063 contributor: fullname: Varki – volume: 113 start-page: 3329 year: 2016 ident: key 20180328170405_cwx108C64 article-title: Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1507706113 contributor: fullname: Perdicchio – volume: 5 start-page: 526 year: 2005 ident: key 20180328170405_cwx108C34 article-title: The sweet and sour of cancer: Glycans as novel therapeutic targets publication-title: Nat Rev Cancer doi: 10.1038/nrc1649 contributor: fullname: Fuster – volume: 124 start-page: 1810 year: 2014 ident: key 20180328170405_cwx108C43 article-title: Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance publication-title: J Clin Invest doi: 10.1172/JCI65899 contributor: fullname: Jandus – volume: 292 start-page: 1029 year: 2017 ident: key 20180328170405_cwx108C84 article-title: Studies on the detection, expression, glycosylation, dimerization, and ligand binding properties of mouse siglec-E publication-title: J Biol Chem doi: 10.1074/jbc.M116.738351 contributor: fullname: Siddiqui – volume: 1143 start-page: 61 year: 2008 ident: key 20180328170405_cwx108C96 article-title: Basic and clinical immunology of Siglecs publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1443.011 contributor: fullname: von Gunten – volume: 7 start-page: 255 year: 2007 ident: key 20180328170405_cwx108C26 article-title: Siglecs and their roles in the immune system publication-title: Nat Rev Immunol doi: 10.1038/nri2056 contributor: fullname: Crocker – volume: 16 start-page: 307 year: 1999 ident: key 20180328170405_cwx108C25 article-title: Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence publication-title: Glycoconj J doi: 10.1023/A:1007026314792 contributor: fullname: Corfield – volume: 26 start-page: 111 issue: 2 year: 2016 ident: key 20180328170405_cwx108C62 article-title: Sialic acids in cancer biology and immunity publication-title: Glycobiology doi: 10.1093/glycob/cwv097 contributor: fullname: Pearce – volume: 113 start-page: 3333 year: 2009 ident: key 20180328170405_cwx108C18 article-title: Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response publication-title: Blood doi: 10.1182/blood-2008-11-187302 contributor: fullname: Carlin – volume: 132 start-page: 18 year: 2011 ident: key 20180328170405_cwx108C16 article-title: Evolution of CD33-related siglecs: Regulating host immune functions and escaping pathogen exploitation? publication-title: Immunology doi: 10.1111/j.1365-2567.2010.03368.x contributor: fullname: Cao – volume: 276 start-page: 178 year: 2017 ident: key 20180328170405_cwx108C33 article-title: Viewing Siglecs through the lens of tumor immunology publication-title: Immunol Rev doi: 10.1111/imr.12526 contributor: fullname: Fraschilla – volume: 30 start-page: 357 year: 2012 ident: key 20180328170405_cwx108C65 article-title: Siglecs and immune regulation publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-075018 contributor: fullname: Pillai – volume: 275 start-page: 16666 year: 2000 ident: key 20180328170405_cwx108C32 article-title: Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack publication-title: J Biol Chem doi: 10.1074/jbc.M001123200 contributor: fullname: Fedarko – volume: 105 start-page: 18936 year: 2008 ident: key 20180328170405_cwx108C37 article-title: Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0803943105 contributor: fullname: Hedlund |
SSID | ssj0016185 |
Score | 2.6054235 |
SecondaryResourceType | review_article |
Snippet | Abstract
Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors... Changes in sialic acids in cancer have been observed for many years. In particular, the increase of sialoglycan density or hypersialylation in tumors has been... |
SourceID | proquest crossref pubmed oup |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 640 |
SubjectTerms | Humans Immune Tolerance - immunology Immunity, Innate Immunotherapy N-Acetylneuraminic Acid - immunology Neoplasms - immunology Neoplasms - therapy Sialic Acid Binding Immunoglobulin-like Lectins - immunology |
Title | Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29309569 https://search.proquest.com/docview/1989558923 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagHOCCoOWxFCojoV5WoZvEiZNjVdFWlQAhWmlvkWM7VcQ2We1m-9hfz4ydh6tSFbhEUZKNtTOfnbH9zTeEfGKJ4EqnyouliHCbUXo559orFPQlziZ6EmGC89dv8fEZO5lG02FH12SXNPlnuf5jXsn_eBWugV8xS_YfPNu_FC7AOfgXjuBhOP6djw2N26wIQGOovCpL5f0sz2daGiGIhU1bMCoOqNW0WOpxiRkherxczVsOrOE6SvT-wg1Vj2Y3stdoQlHSa8uDH1YOVLtO831WXpZifFIPSMPixHItfvXM_NmwaHqJQh4rpM73NDOHGGR27hkujtmvYlmt3ZUJP-mpV_BhsaMpiye45xy6w22QOLBKnbEztrpNd8Z0q3d1bv40nMira99IQTSOh-cXxsUQu6CwYjp83HrKYXfrMXkS8DRC9ufRtGcDYdmAqJVghfb2bGt7ti0UjG5_fSt6uZUReWdiYgKU0xfkeTuzoPsWJi_JI11tkq39SjT1xQ3dpYbra7y5SZ4edHX-tsiPHkXUoog6KKIuimhT0xZF1KKIOiiCR6lF0Stydvjl9ODYawtteBLixwb6VCoLiLwLiA4VljaEwLvAwmVJrARnSihWBL6vcyF1AfOJJJ1okcQ5z5XJ1A5fk42qrvRbQpmfcC1yGTOVs0jyJPRz6PEqEAVMbNNgRHY7A2Zzq6eSWR5EmFmjZ9boI_IRzPvgM53xMzAabnWJSterZYZMwCiC9sIReWO90r-q8-W7e-9sk2cDnt-TjWax0h8g9mzyHYOa36yQiIU |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+sialic+acid-Siglec+interactions+to+reverse+immune+suppression+in+cancer&rft.jtitle=Glycobiology+%28Oxford%29&rft.au=Adams%2C+Olivia+Joan&rft.au=Stanczak%2C+Michal+A&rft.au=von+Gunten%2C+Stephan&rft.au=L%C3%A4ubli%2C+Heinz&rft.date=2018-09-01&rft.eissn=1460-2423&rft.volume=28&rft.issue=9&rft.spage=640&rft_id=info:doi/10.1093%2Fglycob%2Fcwx108&rft_id=info%3Apmid%2F29309569&rft.externalDocID=29309569 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-6658&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-6658&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-6658&client=summon |